feed,title,long_url,short_url
Benzinga,Rigel's Fostamatinib Selected for NIH ACTIV-4 COVID-19 Trial,https://benzinga.com/general/biotech/21/06/21767206/rigels-fostamatinib-selected-for-nih-activ-4-covid-19-trial,https://j.mp/3x9Eb5E
